Compare · AKUS vs HWKN
AKUS vs HWKN
Side-by-side comparison of Akouos Inc. (AKUS) and Hawkins Inc. (HWKN): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AKUS and HWKN operate in Specialty Chemicals (Consumer Discretionary), so they compete in similar markets.
- HWKN carries a market cap of $3.05B.
- HWKN has hit the wire 2 times in the past 4 weeks while AKUS has been quiet.
- HWKN has more recent analyst coverage (7 ratings vs 1 for AKUS).
- Company
- Akouos Inc.
- Hawkins Inc.
- Price
- -
- -
- Market cap
- -
- $3.05B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Specialty Chemicals
- Specialty Chemicals
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- News (4w)
- 0
- 2
- Recent ratings
- 1
- 7
Akouos Inc.
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company is also developing AK-CLRN1 for the auditory manifestations of Usher syndrome 3A, or USH3A; and AK-antiVEGF for vestibular schwannoma. In addition, its precision genetic medicine platform addresses hearing loss related to genes needed for supporting cell function. Akouos, Inc. was incorporated in 2016 and is based in Boston, Massachusetts.
Hawkins Inc.
Hawkins, Inc. blends, manufactures, and distributes chemicals and other specialty ingredients in the United States and internationally. It operates through three segments: Industrial, Water Treatment, and Health and Nutrition. The Industrial segment offers industrial chemicals, products, and services to agriculture, chemical processing, electronics, energy, food, pharmaceutical, and plating industries. This segment primarily provides acids, alkalis, and industrial and food-grade salts. It also receives, stores, and distributes various chemicals, such as liquid caustic soda, sulfuric acid, hydrochloric acid, urea, phosphoric acid, aqua ammonia, and potassium hydroxide. In addition, this segment manufactures sodium hypochlorite and agricultural products, as well as various food-grade products that include liquid phosphates, lactates, and other blended products; repackages water treatment chemicals and bulk industrial chemicals; and performs custom blending of chemicals, and contract and private label bleach packaging. The Water Treatment segment offers chemicals, equipment, and solutions for potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool and agriculture water. The Health and Nutrition segment offers ingredient distribution, processing, and formulation solutions to manufacturers of nutraceutical, functional food and beverage, personal care, dietary supplement and other nutritional food, and health and wellness products. Its products portfolio includes minerals, botanicals and herbs, vitamins and amino acids, excipients, joint products, sweeteners, and enzymes. The company was founded in 1938 and is headquartered in Roseville, Minnesota.
Latest AKUS
- SEC Form SC 13G/A filed by Akouos Inc. (Amendment)
- SEC Form SC 13G/A filed by Akouos Inc. (Amendment)
- SEC Form SC 13G/A filed by Akouos Inc. (Amendment)
- SEC Form SC 13G/A filed by Akouos Inc. (Amendment)
- SEC Form 15-12G filed by Akouos Inc.
- SEC Form EFFECT filed by Akouos Inc.
- SEC Form 4 filed by Walker Paul Edward (tax withholding)
- SEC Form 4 filed by Sonsini Peter W. (tax withholding)
- SEC Form 4 filed by Sandell Scott D to satisfy withholding tax
- SEC Form 4 filed by Mathers Edward T (tax withholding)
Latest HWKN
- Hawkins, Inc. to Participate in Sidoti & Company’s Year-End Virtual Investor Conference
- Amendment: SEC Form SCHEDULE 13G/A filed by Hawkins Inc.
- SEC Form 10-Q filed by Hawkins Inc.
- SEC Form 8-K filed by Hawkins Inc.
- Hawkins, Inc. Reports Second Quarter Fiscal 2027 Results
- Hawkins, Inc. Declares Quarterly Cash Dividend of $0.20 Per Share
- Hawkins, Inc. to Release Second Quarter Fiscal 2027 Financial Results on October 26, 2026
- Hawkins, Inc. Expands into Texas’ Dallas–Fort Worth Region with Acquisition of Eagle Labs, Inc.
- Hawkins, Inc. Expands in Florida with Acquisition of Dave Symonds & Associates, Inc.
- EXECUTIVE VP AND CFO Oldenkamp Jeffrey P. bought $153,510 worth of shares (1,290 units at $119.00), increasing direct ownership by 1% to 104,223 units (SEC Form 4)